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Even if nephrotic syndrome is characterized by massive urinary loss of major plasma proteins, a clear structural character-
ization based on proteomics has never been reported. Urine and plasma of 23 patients with different idiopathic nephrotic
syndromes (10 steroid-sensitive minimal-change nephropathy, seven steroid-resistant FSGS, and six membranous glomeru-
lonephritis) were analyzed with two-dimensional electrophoresis in soft gel, Western blot, and matrix-assisted laser desorp-
tion/ionization time of flight mass spectrometry; 72 urinary components corresponded to fragments of albumin and/or of
1-antitrypsin. Several repetitive fragmentation motives and a few differences among different pathologies were found.
Several (21 of 72) urinary albumin fragments also were detected in plasma, although in lower concentration, suggesting a
preferential excretion. The bulk of components with low molecular weight were detected only in urine, suggesting an in situ
formation; zymograms with albumin as substrate showed the presence in urine of specific proteases. A final but not secondary
point was the characterization of albumin adducts that harbor both the COOH and NH2 terminal parts of the protein,
suggesting the formation of new covalent chemical groups. Altogether, these new findings reveal unexpected structural and
functional aspects of proteinuria that may play a key role in pathogenesis. Characterization of urinary fragmentation patterns
should be extended to other renal diseases.
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N ephrotic syndrome is a clinical condition that is char-acterized by severe hypoproteinemia that is pro-duced by protracted losses in urine of major plasma
proteins that are not counterbalanced by resynthesis. The large
spectrum of renal diseases that cause proteinuria and nephrotic
syndrome ranges from primary diseases such as FSGS, mini-
mal-change nephropathy (MCN), and membranous glomeru-
lonephritis (MGN) to secondary conditions such as diabetes
and amyloidosis (1). Although each renal disease that leads to
proteinuria has specific pathogenic mechanisms (immunologic
versus metabolic versus plasma factors), there is a common
background that includes structural glomerular alterations, in
particular of podocytes, with failure in control of protein traf-
ficking (2–4). The identification of specific biomarkers in urine
should greatly improve the diagnostic potential and also direct
the clinical management. The great accessibility of urine makes
this fluid an ideal target for the search of disease markers (5,6).
The definition of the mechanisms of glomerular filtration of
proteins represented a historic research advance in the early
1980s, when it became clear that, in the presence of a normal slit
diaphragm, sieving properties mainly are a function of both
dimension and charge of any given molecule and that also
conformation plays a role (7). It also was postulated that vari-
ations in protein structure could influence proteinuria in patho-
logic conditions, such as FSGS, but a clear demonstration of this
hypothesis has never been reported so far (8–10). Few data are
available on structural aspects of plasma proteins, in particular
of albumin in human renal diseases that are associated with
nephrotic syndrome. Advances in the field of proteomics allow
today a definite structural approach, including a fine structure
definition, and this new technology potential should prompt us
to revise our knowledge on the structural aspects of albumin
and of other major plasma proteins in nephrotic syndrome.
Within the frame work of a collaborative program on proteom-
ics of biologic fluids, we performed studies on the composition
of plasma and urine in different pathologic conditions that
cause proteinuria, such as primary nephrotic syndrome in chil-
dren (MCN and FSGS) andMGN in adults. We describe here an
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unexpected finding: The presence of fragmentation products of
two major plasma proteins, albumin and 1-antitrypsin
(1AT). The finding of both repetitive fragmentation motives
and specific patterns in different renal diseases suggests com-
mon fragmentation pathways as well as specific mechanisms.
In the case of albumin, we also could describe the formation of
adducts that suggest stable changes of fine protein structure. As
a whole, these data suggest new, unexplored mechanisms un-
derlying kidney damage in primary renal diseases.
Materials and Methods
Patients
Three groups of patients with nephrotic syndrome and different
pathologic backgrounds were enrolled in the study (see Table 1); the
diagnosis was based on clinical data and on renal histology. The
general criteria for enrollment were (1) presence of nephrotic syndrome
(proteinuria40 mg/h per m2) with onset at16 yr of age and, in cases
of steroid dependence and/or resistance, availability of a renal biopsy;
(2) absence of familial traits of nephrotic syndrome and/or relevant
mutations of slit-diaphragm genes (NPHS2, CD2AP, and ACTN4) (11–
14); and (3) presence of nephrotic syndrome at any age with MGN.
Molecular screening was done as already described (CD2 and ACTN)
(12). Blood samples that were collected in EDTA and morning fresh
urine that was collected in sterile conditions were immediately centri-
fuged at 3°C for 10 min, then stored at 80°C for 4 mo before
processing. In all cases, plasma and urine were collected at the begin-
ning of proteinuria (i.e., before the starting of any therapy). Clinical
parameters included blood cell counts, serum creatinine and urea lev-
els, cholesterol, triglycerides, liver function tests, antinuclear antibod-
ies, antineutrophil and antibodies against native DNA, and antibodies
against hepatitis virus B and C. All evaluations were performed ac-
cording to international standardized procedures. Renal biopsies were
processed by standard procedures that included hematoxylin-eosin,
periodic acid-Schiff, and green Masson staining; immunofluorescence
of frozen samples was carried out with a panel of anti-serum protein
antibodies against IgA, IgM, IgG, C3, and C4. Biopsy samples were
evaluated by a pathologist who discussed all relevant aspects with
clinicians. Adult patients and parents (for patients who were younger
than 18 yr) were requested to give their informed consent to DNA
analysis. The following groups of patients were studied.
Steroid-Sensitive or Steroid-Dependent Primary Nephrotic Syn-
drome (MCN). Ten children with nephrotic syndrome had been
treated with prednisolone (2 mg/kg starting dosages followed by ta-
pering) (15,16) and presented a good initial response. Six patients were
in stable remission at the end of the therapeutic cycle; another four
presented steroid dependence and received the minimum amount of
prednisolone required to achieve remission. Renal morphology was
analyzed to define renal lesions before starting therapy with major
immune suppressors. Renal histology showed MCN on the basis of
absence of immune deposits in glomeruli and of histologic lesions.
Electron microscopy was not required in these cases.
Steroid-Resistant Primary Nephrotic Syndrome (FSGS). Seven
children had strict resistance to prednisolone given at the dosage above
and received cyclosporine as associated therapy. Cyclosporine was
given in all cases at 5 mg/kg starting dosage, followed by tapering to
reach the minimum dosage required for maintaining cyclosporine se-
rum levels between 50 and 100 ng/ml (17). All of these patients had a
histologic diagnosis of FSGS on the basis of the presence of at least one
segmental area of glomerulosclerosis in a histologic sample that con-
tained at least six glomeruli.
MGN. Six patients had a histologic diagnosis of MGN performed
at the onset of proteinuria; they were adults with the exception of a
young girl aged 12 yr. After the diagnosis, all patients with MGN
received steroids as single drug (1 to 2 mg/kg) or in combination with
immune suppressors (18) or angiotensin-converting enzyme inhibitors
(ramipril 5 to 8 mg/m2). MGN was considered a primary form on the
basis of negativity of relevant immunologic parameters (antinuclear
antibody, nDNA, C3, and ANCA) and viral tests
Normal Control Subjects. The control group consisted in 10 nor-
mal donors of the laboratory staff (five women and five men; mean age
28 yr; range 22 to 34 yr) and their children (n  6; four girls and two
boys; mean age 4 yr; range 2 to 6 yr). Plasma and morning fresh urine
were collected in sterile conditions and immediately frozen at80°C as
above.
Two-Dimensional Electrophoresis
Two-dimensional (2D) electrophoresis was performed in soft gels as
described previously (19). Sample delipidation was achieved using a
solution that consisted of tri-n-butyl-phosphate:acetone:methanol (1:12:
1), cooled in ice. Fourteen milliliters of this mixture was added to each
sample to reach a final acetone concentration of 80% (vol/vol) and
incubated at 4°C for 90 min. The precipitate was pelleted by centrifu-
gation at 2800  g for 20 min at 4°C. After washing with the same
dilapidating solution, it was centrifuged again and then air-dried.
Finally, samples were dissolved in the focusing solution (7 M urea, 2 M
thiourea, 4% [wt/vol] 3-[3-(cholamidopropyl)-dimethylammonio]-1-
propanesulphonate, 5 mM tributyl-phosphina, 20 mM iodoacetamide,
40 mM Tris, 0.1 mM EDTA [pH 8.5], and a 1% [vol/vol] carrier
Table 1. Clinical and biochemical parameters in 23 patients with idiopathic nephrotic syndrome according to renal
pathology (10 steroid-sensitive MCN, seven steroid-resistant FSGS, and six MGN)a
n Gender(M/F)
Age
(yr)
Age at
Onset
(yr)
Proteinuria
(g/24 h)
Serum
Creatinine
(mg/dl)
Serum
Cholesterol
(mg/dl)
Serum
Albumin
(g/dl)
Therapy
(St/CsA/ACEi)
Steroid-sensitive MCN 10 7/3 8.2 (3 to 16) 3.0 (1.5 to 6) 6.5 (2 to 7) 0.5 (0.3 to 0.8) 348 (230 to 670) 1.2 (0.9 to 1.4) 10/0/4
Steroid-resistant FSGS 7 5/2 8 (5 to 16) 3 (1 to 7) 4.8 (2 to 7) 0.6 (0.4 to 1.0) 300 (200 to 460) 1.6 (1.1 to 2.2) 6/6/4
MGN 6 4/2 39 (12 to 55) 36 (10 to 53) 6 (1 to 8) 1.1 (0.5 to 1.4) 280 (220 to 500) 1.5 (1.1 to 2) 6/0/6
aIn all cases, plasma and urine were collected before any therapy was started and before a correct diagnosis was made on
the basis of clinical and pathologic findings. All patients who were classified as steroid-sensitive MCN presented a good
sensitivity to steroids, although with some relapses of proteinuria. In these cases, MCN was diagnosed on the basis of the
absence of Ig deposition in glomeruli and of any histologic alteration. Electron microscopy was not required in these cases.
Results are given as mean range of variation. NS, nephrotic syndrome; MCN, minimal-change nephropathy; St, steroids; CsA,
cyclosporine; ACEi, angiotensin-converting enzyme inhibitors.
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ampholyte cocktail) that contained 60% of the pH 3.5 to 10 and 40% of
the pH 4 to 8 intervals. Before isoelectric focusing, samples were
incubated in this solution for 3 h to allow proper reduction and alky-
lation. For prevention of overalkylation during the isoelectric focusing
step, excess of iodoacetamide was destroyed by adding a molar amount
of dithiothreitol. The first dimension strips that were used for 2D maps
were 18-cm-long, soft, homemade, immobilized-pH-gradient gels. In
the second dimension, proteins were separated on the basis of their size
in 6 to 16% T gradient polyacrylamide gel slabs that were 180  160 
1.5 mm.
For Western blot, proteins were transblotted to nitrocellulose mem-
branes Protean BA (Schleicher & Schuell, Dassel, Germany) with a
Novablot semidry system using a continuous buffer system with
2-amino 2-idroxymethyl 1,3-propanediol tris 38 mM, glycine 39 mM,
SDS 0.035%, and methanol 20%. The transfer was achieved at 1.55
mA/cm2 for 1.5 h.
Gel/Membrane Staining and Image Analysis
After separation in SDS-PAGE gels, the proteins were visualized by
a double-staining procedure: First the methyl-trichloroacetate negative
staining (20) followed by the silver staining or Blue silver colloidal
Coomassie (21) for preparative mass spectrometry analysis. Images of
stained gels were digitized using a GS800 photometer and were ac-
quired using a Versa DOC 400. All images were analyzed with the PD
Quest software (Bio-Rad, Hercules, CA). Chemiluminescence was used
detect proteins after Western blot. Hybridization was preceded by an
overnight incubation at room temperature with a blocking solution of
3% BSA in TBS Tween 0.15% (vol/vol; TBST). Incubation with primary
anti-human albumin and anti-human 1AT antibodies (see the Valida-
tion of Antibody Specificity section) diluted 1:40,000 (vol/vol) was
performed in 3% (wt/vol) BSA in TBST for 2 h at room temperature.
The membrane then was washed with TBST four times, 15 min each,
before the incubation with peroxidase-conjugated goat anti-rabbit IgG
diluted 1:40,000 (vol/vol) in 3% (wt/vol) BSA in TBST for 2 h at room
temperature. The membrane then was washed four times, 15 min each,
before developing the immune blot with the Super-Signal West Pico
chemiluminescent Substrate (Pierce, Rockford, IL). The detection of
fluorescence signals was acquired with Versa Doc 4000 (Bio-Rad).
Validation of Antibody Specificity
For Western blot, the following two antibodies were used: (1) Poly-
clonal rabbit anti-human albumin (A0001; Dako, Glostrup, Denmark)
and (2) polyclonal rabbit anti-human 1AT (A0012; Dako). The second
antibody was a peroxidase-conjugated goat anti-rabbit IgG from Vector
Laboratories (Burlingame, CA). Anti-actin antibodies from the same
source were used to exclude cross-reactions. The specificity of anti-
albumin antibodies also was tested by repeating Western blot after
pull-down of the protein, in which case no reactivity was observed.
Lack of cross-immunoreactivity also can be defined on the basis of
comparison between Western blot for albumin and for 1AT.
Tryptic Digestion and Matrix-Assisted Laser Desorption/
Ionization Time of Flight Protein Identifications
Protein spots were excised from 2D PAGE gel, and cysteines were
reduced with dithiothreitol and alkylated with iodoacetamide. After
derivatization, the samples were incubated at 37°C for 16 to 18 h with
20 l of a buffer solution, 50 mM ammonium bicarbonate, that con-
tained 10 ng/l sequence-grade trypsin (Sigma, St. Louis, MO). The
reaction was stopped by adding a final concentration of 0.1% trifluoro-
acetic acid and by freezing gel plugs at20°C. After digestion, samples
were used for protein identification by mass fingerprint matrix-assisted
laser desorption/ionization time of flight (MALDI-TOF) analysis.
For the mass spectrometric analysis, the tryptic digests were ex-
tracted by ZipTip C18 reverse phase according to the manufacturer
(Millipore, Bedford, CA). Elution and spotting were obtained with a
50% acetonitrile/water solution saturated with -cyano-4-hydroxycin-
namic acid (Sigma) and deposited onto individual spots on the target
MTP Ground Steel 384 (Bruker Daltonics, Billerica, CA). MALDI-TOF
spectra were obtained by Reflex IV time-of-flight instrument (Bruker
Daltonics) equipped with a 337-nm nitrogen laser. Mass spectra were
acquired in reflectron-positive ion mode at a voltage of 20.00, 16.80, and
8.90 kV for ion source 1, 2, and lens, respectively, and 23.00 kV for
Reflectron in the 700- to 4500-m/z range. A 50-pmol/l peptide-mix
solution of angiotensin I (1296.68 Da), ACTH 18-39 (2465.19 Da), bra-
dykinin (1060.57 Da), renin substrate (1758.93 Da), and Glu-FibrinoPep
(1570.67 Da) was used as external calibration standard. Monoisotopic
peaks were selected for peptide fingerprinting using the FlexAnalysis
2.0 software (Bruker Daltonics), and BioTools Version 2.2 was used to
submit monoisotopic peptide masses for protein identification. Mass
spectrometry (MS) data inference was compared with the National
Center for Biotechnology Information nonredundant database data by
the MASCOT software (Matrix Science, http://www.matrixscience-
.com). Protein identification was considered significant at P 0.05 with
respect to a random matching event. The query was restricted to
human proteins, the maximum tolerance for masses was 100 ppm after
an internal calibration using autolytic trypsin product, at most one
miss-cleavage for tryptic peptides was allowed, and the modifications
accepted were carbamidomethylation of cysteines and possible oxida-
tion of methionines. In accordance with the Proposed Publication
Guidelines for the Analysis and Documentation of Peptide and Protein
Identifications (Paris consensus), we included in Table 2 the complete
figures of merit regarding the MS data. In particular, these include (1)
matched peptides (the number of tryptic peptides actually aligned on
the identified protein sequence), (2) sequence coverage (the percentage
of the identified protein sequence covered by the MS data), and (3)
identification score (a probabilistic measure of the goodness of the MS
protein identification). All of the included protein identifications were
significant at P  0.05.
Zymograms
Human serum albumin (Baxter) was reduced in 8 M urea, 65 mM
dithioerythritol, 100 mM Tris(hydroxymethyl)aminomethane (TRIS),
and 0.1 mM EDTA for 1.5 h at room temperature; 260 mM iodoacet-
amide then was added for 1 h at room temperature. Overalkylation was
stopped by addition of 260 mM of dithioerythritol. Albumin finally was
dialyzed three times against 10 L of 10 mM TRIS-HCl (pH 8.8).
Albumin zymography was performed on 8 to 16% polyacrylamide
gels (160 140 0.75 mm) that contained 2 mg/ml carboxymethylated
albumin under Laemmli conditions (22). After electrophoresis (12 mA,
constant current at 12°C), gels were washed twice in 250 ml of 2.5%
Triton X-100 (30 min each at 4°C) and incubated in 50 mM TRIS-HCl
and 5 mM CaCl2 (pH 7.8; 48 h, 37°C). Gels were fixed in 40% ethanol
and 10% acetic acid and stained with 0.2% Coomassie brilliant blue
G-250 (40% ethanol, 10% acetic acid) and destained appropriately (40%
ethanol, 10% acetic acid). Gelatinase activity was evident as cleared
regions.
Results
Fresh urine was obtained from normal children and adults and
from patients with nephrotic syndrome at the start of proteinuria.
The study cohorts consisted of two groups of children with pri-
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mary nephrotic syndrome and different response to steroids and
an additional group that consisted mainly of adults with MGN.
After the therapeutic approach, nephrotic children were subdi-
vided in responsive and resistant to steroids, and in case of de-
pendence or resistance, renal histology was evaluated to exclude
other primary and secondary pathologies.
Normal urine from adults and children was analyzed re-
petitively by a combination of 2D electrophoresis and MS,
and the same pattern was always observed. Owing to the
very low protein level in normal urine, gels were overloaded
with 2 ml of normal urine (containing 200 g of total pro-
tein); a major band of uromodulin (acid protein with 80 kD
molecular weight) was evident, together with a few other
acid proteins between 50 and 20 kD and a low amount of
intact albumin (Figure 1, A and B). Therefore, the constant
pattern of normal urine in both children and adults was
characterized by the absence of albumin fragments. The com-
position of nephrotic urine was remarkably different. Nu-
merous fragments of albumin and of 1AT in fact were
detected in urine of all patients with a few patterns common
Table 2. Urinary and plasma proteins from patients with nephrotic syndrome were characterized by two-
dimensional electrophoresis-Western blot and by MALDI-TOFa
Spot Source IdentificationTechnique Protein Name NCBI SC% Score
1 Urine WB/MS Albumin gi4502027 21 88
2 Urine WB/MS Albumin gi4502027 20 84
3 Urine/plasma WB/MS Albumin gi4502027 54 305
4 Urine/plasma WB/MS Albumin gi4502027 50 246
5 Urine WB/MS Albumin gi4502027 15 77
6 Urine WB/MS Albumin gi4502027 25 69
7 Urine WB/MS Albumin gi4502027 12 78
8 Urine WB/MS Albumin gi4502027 27 128
9 Urine WB/MS Albumin gi4502027 23 66
10 Urine WB/MS Albumin gi4502027 18 65
11 Urine WB/MS Albumin gi4502027 8 64
12 Urine WB/MS Albumin gi4502027 12 74
13 Urine/plasma WB/MS Albumin gi4502027 18 88
14 to 28 Urine WB Albumin gi4502027
29 Urine/plasma WB Albumin gi4502027
30 to 41 Urine WB Albumin gi4502027
42 to 47 Urine/plasma WB Albumin gi4502027
48 to 50 Urine WB Albumin gi4502027
51 Urine/plasma WB Albumin gi4502027
52 Urine WB Albumin gi4502027
53 Urine/plasma WB Albumin gi4502027
54 Urine WB Albumin gi4502027
55 Urine/plasma WB Albumin gi4502027
56 to 57 Urine WB Albumin gi4502027
58 to 63 Urine/plasma WB Albumin gi4502027
64 Urine/plasma WB  1AT gi50363217
65 Urine WB  1AT gi50363217
66 Urine WB/MS  1AT gi50363217 20 51
67 Urine WB  1AT gi50363217
68 Urine WB/MS  1AT gi50363217 18 31
69 Urine WB  1AT gi50363217
70 Urine/plasma WB  1AT gi50363217
71 to 72 Urine WB  1AT gi50363217
aA total of 72 spots were identified as fragments of albumin and/or of 1-antitrypsin (1AT). Most (n  72) were recovered
from urine, and only some (n  21) were also detected in plasma. According to the Proposed Publication Guidelines for the
Analysis and Documentation of Peptide and Protein Identifications (Paris consensus), we included in this table the complete
figures of merit regarding the mass spectrometry (MS) data. In particular, these include sequence coverage (SC%), indicating
the percentage of the identified protein sequence covered by the MS data, and identification score (Score), indicating a
probabilistic measure of the goodness of the MS protein identification. All included protein identifications were significant at
P  0.05. MALDI-TOF, matrix-assisted laser desorption/ionization time of flight; NCBI, National Center for Biotechnology
Information; WB, Western blot.
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to different diseases and several differences that are de-
scribed separately next.
Albumin
Intact albumin was the major protein in nephrotic urine. In
parallel, numerous albumin fragments that covered the entire
range of molecular weight from 64 to 20 kD were detected. An
example is given in Figure 1E (Western blot with anti-albumin
antibodies) and shows the pattern of a morning fresh urine
sample that was obtained from a child with steroid resistance
and FSGS; by comparison, a urine sample that was obtained
from a child with steroid-sensitive nephrotic syndrome is
Figure 1. Two-dimensional (2D) electrophoresis and Coomassie staining of a single spot of fresh urine obtained from a normal volunteer
(A) and from patients with nephrotic syndrome caused by different renal pathologies such as FSGS (D), minimal-change nephropathy
(MCN; G), and membranous glomerulonephritis (MGN; L). Western blot with anti-albumin and anti–1-antitrypsin (anti-1AT)
polyclonal antibodies of the same urinary sample as above: normal-albumin (B), normal-1AT (C), FSGS-albumin (E), FSGS-1AT (F),
MCN-albumin (H), MCN-1AT (I), MGN-albumin (M), and MGN-1AT (N). 2D electrophoresis was performed in soft gels according
to the technique described by Bruschi et al. (19). In case of normal urine, 2 ml of urine (containing 200 g of total protein) was loaded
onto the gel. In case of heavy proteinuria, 1 l of urine (containing 200 g of protein) was loaded.
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shown in Figure 1, G and H. In both cases, the same amount of
protein analyzed in normal urine (1 l, containing 200 g of
protein) was loaded on gels. The presence of albumin frag-
ments was confirmed by Western blot analysis of several urine
samples from patients both with steroid-resistant FSGS (Fig-
ures 1, D through F, and 2, tracks 10 through 16) and with
steroid-sensitive MCN (Figures 1, G and H, and 2, tracks 4
through 9 and tracks 17 through 20). Figure 2 shows the pattern
of urinary albumin in both reduced ( mercaptoethanol) and
nonreduced ( mercaptoethanol) conditions, indicating that
some albumin fragments react with each other and form aggre-
gates through disulphide bridges that are destroyed by  mer-
captoethanol. Finally, albumin fragments also were detected
with some differences in patients with MGN (Figure 1, L and
M). These patients lacked, in fact, the isoforms with the lowest
molecular weight. A comprehensive characterization of the
differences between FSGS/MCN and MGN by dual labeling is
in progress and will be presented in the near future.
Overall, 63 fragments of albumin were detected clearly in
nephrotic urine (Figure 3); they were recovered from the gel
and analyzed by MS that unequivocally confirmed their iden-
tity. The molecular weight of albumin fragments was calculated
both from the human serum albumin (HSA) sequence that was
obtained from the mass fingerprint experiments and from the
SDS-PAGE. Both molecular weight values showed a good cor-
relation, demonstrating that most of the HSA sequence was
investigated in the MALDI-TOF-MS experiments. Moreover,
few protein spots (Figure 4) showed consistently a peculiar
distribution of the fingerprint peptide pattern that contained
both the N-terminal region and the C-terminal domain with a
complete lack of any MS signals for the internal sequence
region. The reconstructed joint domains were calculated from
mass fingerprint data that defined the HSA sequence regions
that consistently were matched by experimentally measured
tryptic peptides. In addition, the molecular weights of albumin
spots estimated from 2D PAGE were not compatible with an
albumin isoform that spanned the complete continuous se-
quence. Such tryptic peptide distribution could not be ex-
plained directly by the presence of the 16 disulfide bridges that
were reported for the HSA structure given the strong reducing
conditions that were used in sample preparation and separa-
tion. Therefore, we might speculate on the presence of covalent
bound intramolecular cross-links that would be resistant to the
strong denaturing conditions that were used in protein separa-
tion.
To exclude that the pattern of albumin fragmentation that
was observed in nephrotic urine was due, in fact, to proteases
in the tubule and/or in urine, we repeated the same analysis
with Western blot in the companion plasma, where a large part
of fragmentation products were recognized. The results are
shown in Figure 5 (a 2D analysis and Western blot of plasma
Figure 2. Gradient electrophoresis in the presence and in the
absence of -mercaptoethanol and Western blot with anti-albu-
min antibodies of urine from normal donors (2 ml of urine;
tracks 1 through 3, patients with steroid-sensitive MCN (tracks
4 through 9 and tracks 17 through 20), and patients with
steroid-resistant FSGS (tracks 10 through 16). In the presence of
-mercaptoethanol, several low molecular isoforms of albumin
were detected. In its absence, a few low molecular weight
isoforms still were present with several dimers of albumin
indicating the formation of disulphide bridges. Normal urine
did not contain low or high molecular weight isoforms.
Figure 3. 2D electrophoresis of the sample of urine of Figure 1D,
in which all spots that were characterized by mass spectrome-
try (MS) and/or Western blot are numbered and described in
Table 2.
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albumin in one patient per group) and are summarized in Table
2. Twenty-one of the spots that were characterized as albumin/
1AT in urine also were present in plasma even at a lower
concentration, suggesting preferential excretion of low molec-
ular components. However, a lot of low molecular weight
isoforms that were observed in urine were not present in
plasma (see Table 2), suggesting an in situ fragmentation pro-
cess that implies the presence of proteases in urine. In general,
the components that were detected only in urine presented a
low molecular weight and migrated to an area of gels indicated
by a square in gels of Figure 1. On this basis, the presence of
urinary proteases was postulated and experiments were
planned to demonstrate their existence (see the Urinary Pro-
teases Specific for Albumin section).
1AT
1AT is practically absent in normal urine (Figure 1, A and
C). Intact and fragmented 1AT instead is well evident in urine
of all different cohorts of patients (Figure 1, F, I, and N). MS
confirmed identity of 1AT (Table 2). As for albumin also for
1AT, experiments with Western blot were carried out in
plasma, where the presence of a part of 1AT fragments could
be confirmed (Figure 5). Again, comparison of plasma and
urine 1AT composition showed that a few isoforms with low
molecular weight are produced in situ as an effect of proteases.
Urinary Proteases Specific for Albumin
To explain the formation of albumin fragments in urine, we
performed a zymogram with albumin as substrate that indi-
cated the presence of specific proteases. Comparison of normal
and nephrotic urine demonstrated the presence of two major
bands with protease activity that were upregulated in nephrotic
patients (Figure 6). This finding indirectly supports the exis-
tence of a specific mechanism for in situ digestion of albumin in
urine.
Discussion
This study was aimed at defining protein composition of
urine and plasma in nephrotic patients and at revaluating
relevant structural aspects of major proteins such as albumin.
For this purpose, we took advantage of the progress that has
been made in the vast area of proteomics. Different clinical and
pathologic conditions that are determined by different mecha-
nisms such as primary nephrotic syndrome in children (perme-
ability factors?) and MGN (immune complex) (23,24) were con-
sidered. The following relevant findings reveal unexpected
Figure 4. Schematic representation of urinary albumin peptide composition as assigned by matrix-assisted laser desorption/
ionization time of flight MS to spots that were recovered from 2D gels. A few spots (1, 2, 3, 4, 5, and 9) represented fragments of
albumin. Several other spots harbored both the N-terminal region and in the C-terminal domain with a complete lack of any MS
signals of the internal sequence region.
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elements that suggest pathogenic implications and warrant
wide discussion. The first regards the composition of nephrotic
urine that practically contains only intact and fragmentation
products of albumin and of 1AT. With the exception of a few
low molecular weight urinary isoforms, some albumin and
1AT fragments also were detected in plasma, suggesting that
fragmentation takes place at this site. Few isoforms instead are
produced in urine, and we could demonstrate the presence in
urine of specific proteases. A parallel aspect is how fragmen-
tation influences renal handling of both proteins, which is the
reason that nephrotic urine is enriched in fragments. The final
point is about albumin adducts and their significance.
It is relevant that most of the proteins that are detected in
urine of children with nephrotic syndrome correspond to intact
albumin and 1AT or their fragments as it clearly emerges from
the comparison of the 2D gels of the same urinary sample
stained by Coomassie and Western blot reported in Figure 1.
MS confirmed this conclusion.
To our knowledge, the finding of protein fragments in serum
and urine of patients with renal diseases is new and suggests
different fragmentation mechanisms. The high concentration of
albumin fragments in nephrotic urine suggests a preferential
urinary excretion and reflects the partial maintenance of size
selectivity properties of the kidney. Albumin fragments ac-
count, in fact, for 25 to 30% of total albumin in urine of ne-
phrotic patients, whereas their proportion in serum does not
exceed 5%. Considering that in nephrotic syndrome at least 2 to
3 g of albumin is lost every day in urine and that up to 1 g (30%)
is represented by fragments, it can be concluded that almost
30 g of fragments is cleared monthly from plasma, accounting
for 30% of the albumin pool in a patient who weighs 30 kg. Our
conclusion is that preferential urinary excretion of albumin
fragments in nephrotic patients represents an efficient depura-
tive mechanism that restores normal albumin composition in
plasma, and the same considerations apply to 1AT. It is critical
to this conclusion that also normal plasma contains albumin
fragments, which suggests that in nephrotic syndrome the frag-
mentation process is amplified. This seems even more interest-
ing for 1AT, which acts as a major circulating defense against
exogenous proteolysis enzymes of viral or bacterial derivation
and also controls the proteolysis response that is triggered by
normal immunologic process. It is a suicide protein in the sense
that it attracts proteases at a bait region and is degraded after
binding by the proteosome (25,26). To our knowledge, nothing
like this has been described before in human pathology, and
Figure 5. 2D electrophoresis and Western blot with anti-albu-
min (A, C, E, and G) and anti-1AT (B, D, F, and H) polyclonal
antibodies of plasma from normal volunteers (A and B) and
from patients with nephrotic syndrome caused by different
renal pathologies such as FSGS (C and D), MCN (E and F), and
MGN (G and H).
Figure 6. Zymograms with albumin as substrate of normal urine
(tracks 1 and 2) and urine from patients with nephrotic syn-
drome caused by various types of renal diseases: Steroid-resis-
tant FSGS (tracks 3 through 8), steroid-sensitive MCN (tracks 9
through 13), andMGN (tracks 14 through 16). Two major bands
common to both normal and nephrotic urine are present at
different concentrations. Arrow indicates a band with protease
activity that is present only in urine of patients with FSGS. ST
indicates molecular weight standards (Bio-Rad).
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experimental and in vitromodels are required to investigate this
aspect further. It seems relevant that inactivation of 1AT by
leukocytes has been reported extensively in the literature, this
mechanism involving the production of free radicals from ac-
tivated neutrophils and activation of specific proteases (27–29).
This observation reinforces the hypothesis of a role of free
radicals in nephrotic syndrome that has been proposed in the
past but never received experimental support.
A final but not secondary point is the description of albumin
adducts. They were characterized by MS as peptides that har-
bor both the COOH and NH2 terminal parts of the protein.
Such evidence cannot be explained simply by the presence of
disulfide bridges or the adventitious lack of MS signals given
the 2D electrophoresis separation conditions and the calculated
molecular weight. These data might be suggestive of the pres-
ence of a covalent chemical adduct that links the two otherwise
separated parts of albumin (30). Such cross-links have been
described as end products of Amadori compounds that are
generated from the glycation of lysine residues. Nevertheless,
the large number of chemical structures that are formed during
nonezymatic glycation does not allow us to draw any conclu-
sion on the new molecules described here (31). The presence of
albumin adducts in FSGS is new and obviously will receive
further attention in the near future for a definite chemical
characterization.
Conclusion
Albumin and 1AT fragments represent the major proteins
in urine of patients with nephrotic syndrome, where at least 50
isoforms of these proteins were characterized by proteomics
analysis. Most of these isoforms derive from plasma, but a few
were formed in situ by specific proteolysis. Albumin adducts
that harbor both the COOH and NH2 terminal parts of the
protein also were detected, suggesting the formation of cova-
lent chemical adducts. These new findings reveal unexpected
structural and functional aspects of proteinuria that may play a
key role in pathogenesis.
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